Table 1.

Clinical findings

Patient no.Age/sexInterval between abciximab exposures, wkPlatelet levelDays required to reach 100 × 109/LBleeding symptomsOther
PretreatmentNadir
53/F “Normal” 1 × 109/L Petechiae, ecchymoses, gastrointestinal bleeding Emesis and hypotension 15 minutes after infusion was started, abciximab stopped 
75/F 15 190 × 109/L 6 × 109/L > 3 Petechiae, oozing from venipuncture sites  
45/F “Normal” 4 × 109/L < 5 Petechiae, oozing from venipuncture sites  
60/M “Normal” 1 × 109/L Petechiae  
63/M 142 × 109/L 1 × 109/L Petechiae, oozing from venipuncture sites Had drop in platelets from 199 × 109/L to 139 × 109/L after first treatment 
48/M 139 × 109/L 6 × 109/L Petechiae, ecchymoses  
41/M 239 × 109/L 5 × 109/L Petechiae  
55/M 205 × 109/L 3 × 109/L Petechiae, ecchymoses  
60/M 150 × 109/L 2 × 109/L Petechia, oozing from venipuncture sites, intrapulmonary hemorrhage Anaphylactic reaction, required mechanical ventilation 
Patient no.Age/sexInterval between abciximab exposures, wkPlatelet levelDays required to reach 100 × 109/LBleeding symptomsOther
PretreatmentNadir
53/F “Normal” 1 × 109/L Petechiae, ecchymoses, gastrointestinal bleeding Emesis and hypotension 15 minutes after infusion was started, abciximab stopped 
75/F 15 190 × 109/L 6 × 109/L > 3 Petechiae, oozing from venipuncture sites  
45/F “Normal” 4 × 109/L < 5 Petechiae, oozing from venipuncture sites  
60/M “Normal” 1 × 109/L Petechiae  
63/M 142 × 109/L 1 × 109/L Petechiae, oozing from venipuncture sites Had drop in platelets from 199 × 109/L to 139 × 109/L after first treatment 
48/M 139 × 109/L 6 × 109/L Petechiae, ecchymoses  
41/M 239 × 109/L 5 × 109/L Petechiae  
55/M 205 × 109/L 3 × 109/L Petechiae, ecchymoses  
60/M 150 × 109/L 2 × 109/L Petechia, oozing from venipuncture sites, intrapulmonary hemorrhage Anaphylactic reaction, required mechanical ventilation 
Close Modal

or Create an Account

Close Modal
Close Modal